WINTOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
WINDTREE THERAPEUTICS INC /DE/
Financials through Q3 FY2025, quarter ended Sep 30, 2025Last filing: 10-Q on Nov 19, 2025
$0.00+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $26.68K
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Windtree Therapeutics has not reported a dividend
No dividend per share appears in Windtree Therapeutics's annual filings since fiscal 2009.